
NEJM This Week — April 17, 2025
NEJM This Week
00:00
Intro
This chapter explores the efficacy of obinutuzumab for lupus nephritis treatment and the results of a clinical trial on tecovirimat for M-POX. It underscores the significance of thorough human efficacy trials and the careful interpretation of uncontrolled study outcomes.
Transcript
Play full episode